Advertisement
Research Article Free access | 10.1172/JCI110843
Department of Immunology, Scripps Clinic and Research Foundation, La Jolla, California 92037
Department of Clinical Research, Scripps Clinic and Research Foundation, La Jolla, California 92037
Division of Clinical Immunology and Allergy, School of Medicine, University of California, Los Angeles, California 90024
Division of Pediatric Allergy and Immunology, School of Medicine, University of California, San Diego, La Jolla, California 92093
Find articles by Thompson, L. in: JCI | PubMed | Google Scholar
Department of Immunology, Scripps Clinic and Research Foundation, La Jolla, California 92037
Department of Clinical Research, Scripps Clinic and Research Foundation, La Jolla, California 92037
Division of Clinical Immunology and Allergy, School of Medicine, University of California, Los Angeles, California 90024
Division of Pediatric Allergy and Immunology, School of Medicine, University of California, San Diego, La Jolla, California 92093
Find articles by Saxon, A. in: JCI | PubMed | Google Scholar
Department of Immunology, Scripps Clinic and Research Foundation, La Jolla, California 92037
Department of Clinical Research, Scripps Clinic and Research Foundation, La Jolla, California 92037
Division of Clinical Immunology and Allergy, School of Medicine, University of California, Los Angeles, California 90024
Division of Pediatric Allergy and Immunology, School of Medicine, University of California, San Diego, La Jolla, California 92093
Find articles by O'Connor, R. in: JCI | PubMed | Google Scholar
Department of Immunology, Scripps Clinic and Research Foundation, La Jolla, California 92037
Department of Clinical Research, Scripps Clinic and Research Foundation, La Jolla, California 92037
Division of Clinical Immunology and Allergy, School of Medicine, University of California, Los Angeles, California 90024
Division of Pediatric Allergy and Immunology, School of Medicine, University of California, San Diego, La Jolla, California 92093
Find articles by Fox, R. in: JCI | PubMed | Google Scholar
Published April 1, 1983 - More info
T lymphocytes from control subjects were separated into subsets using monoclonal antibodies of the OKT series and complement lysis and analyzed for ecto-5′-nucleotidase activity both by quantitative radiochemical assay and a histochemical stain. T cells from 15 control subjects contained 54±4% OKT4+ (helper/inducer) cells and 32±3% OKT8+ (cytotoxic/suppressor) cells. Total T cell ecto-5′-nucleotidase activity was 10.9±2.1 nmol/h per 106 cells with 25±7% positive by histochemical stain. Ecto-5′-nucleotidase activity in OKT4-enriched populations was 5.43±1.8 nmol/h per 106 cells with 14±2% positive by histochemical stain; that in OKT8-enriched populations was 17.1±5.9 nmol/h per 106 cells with 35±8% positive by histochemical stain.
Two of four patients with congenital agammaglobulinemia and four of seven patients with common variable immunodeficiency had decreased proportions of OKT4+ T cells with corresponding increases in the proportions of OKT8+ T cells (OKT4/OKT8 = 0.60 to 1.0 as compared with 1.7±0.2 for control subjects). All four patients with congenital agammaglobulinemia, and three of seven patients with common variable immunodeficiency also had low T cell ecto-5′-nucleotidase activity (<5.5 nmol/h per 106 cells). Ecto-5′-nucleotidase activity in OKT4- enriched populations isolated from four patients with low total T cell activity was 2.85±0.90 nmol/h per 106 cells with 10±4% positive by histochemical stain; that in OKT8-enriched populations was 6.82±1.7 nmol/h per 106 cells with 7.5±3% positive by histochemical stain. Thus, the number of ecto-5′-nucleotidase positive cells is decreased, especially in the OKT8+ subpopulation, and the low total T cell ecto-5′-nucleotidase activity seen in these patients is due to fewer positive cells rather than to substantially less activity per cell.
Our data indicate that ecto-5′-nucleotidase activity defines two subpopulations of T lymphocytes (ecto-5′-nucleotidase positive and negative), the proportions of which are markedly altered in many patients with hypogammaglobulinemia. In preliminary studies with seven patients, increased numbers of ecto-5′-nucleotidase negative T cells appeared to correlate with increased suppressor T cell activity toward in vitro immunoglobulin synthesis. Therefore, ecto-5′-nucleotidase may be a useful cell surface marker in the study of imbalances of regulatory T cell subsets in patients with antibody synthesis disorders.